Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
12/2003
12/11/2003WO2003101983A1 Tetrahydropyran derivative
12/11/2003WO2003033500B1 Photoactivable nitrogen bases
12/11/2003WO2003006468A3 Polymerisable charge transport compounds
12/11/2003US20030229115 Organ rejection disease; autoimmune disease; immunosuppressants
12/11/2003US20030229098 Polycyclic compounds exhibiting anti-tumor activities
12/11/2003US20030229075 Induce immunology response; genetic engineering; gene expression; crystallization
12/11/2003US20030228355 Precipitation of lipid; fineness particle size
12/11/2003US20030226996 Organic semiconductor material and organic electronic device
12/11/2003CA2486933A1 Tetrahydropyran derivative
12/11/2003CA2486191A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
12/10/2003EP1368358A1 Isoxazoline derivatives as anti-depressants
12/10/2003EP1368354A1 Modulators of chemokine receptor activity
12/10/2003CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use
12/09/2003US6660766 Bioavailability
12/04/2003WO2003099821A1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
12/04/2003WO2003059878A3 Thieno (3, 2-b) pyridones as antiviral compounds
12/04/2003WO2003050122A3 Mitotic kinesin inhibitors
12/04/2003WO2003016561A3 Method for the production of cna
12/04/2003US20030225269 Inhibitors of interleukin-1beta converting enzyme
12/04/2003US20030225268 Diazabicyclic CNS active agents
12/04/2003US20030225094 E.g, 4-(2-((6R,12aR)-6-benzo(1,3)dioxol-5-yl-1,4-dioxo -3,4,6,7,12,12a-hexahydro-1H-pyrazino-(1',2':1,6)pyrido(3,4-b) indol-2-yl)ethyl)-benzenesulfonamide; inhibitors of cyclic guanosine 3', 5'-monophosphate specific phosphodiesterase
12/04/2003US20030225063 Treating autoimmune diseases mediated by cathepsin S
12/04/2003US20030225062 Treating autoimmune diseases mediated by cathepsin S
12/04/2003US20030225038 Adenosine receptor antagonists and methods of making and using the same
12/03/2003EP1367058A1 Tetrahydropyran derivatives
12/03/2003EP1366049A2 Pirazino[1'2':1,6]pyrido[3,4-b]indole derivatives
12/03/2003EP1366048A2 Pyrazolopyridine derivatives
12/02/2003US6657884 High density non-volatile memory device
12/02/2003US6656947 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
12/02/2003US6656612 Heterocyclic compounds, materials for light emitting devices and light emitting devices using the same
11/2003
11/27/2003WO2003097647A1 Vitamin-mitomycin conjugates
11/27/2003WO2003097642A1 Anti-tumour polycyclic carboxamides
11/27/2003WO2003097608A2 Opioid and opioid-like compounds and uses thereof
11/27/2003WO2003097356A1 Camptothecin derivatives and polymeric conjugates thereof
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003022852A3 Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
11/27/2003US20030220499 Novel spiro compounds
11/27/2003US20030220387 Nitrogen compounds such as 3,9-Difluoro-12,13-dihydro-13-((3,6 -anhydro)-beta-D- glucopyranosyl)-5H-indolo(2,3-a)pyrrolo(3,4 -c)carbazole-5,7(6H)-dione, used as topoisomerase inhibitors, antiproliferative or antitumor agents
11/27/2003US20030220279 Decreasing cell proliferation by decreasing levels of PP5
11/27/2003CA2486157A1 Opioid and opioid-like compounds and uses thereof
11/27/2003CA2485006A1 Camptothecin derivatives and polymeric conjugates thereof
11/26/2003EP1364950A1 Pyridopyrimidine or naphthyridine derivative
11/26/2003EP1363916A2 Emissive multichromophoric systems
11/26/2003EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363705A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
11/26/2003CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use
11/25/2003US6653473 Fluorescent quenching detection reagents and methods
11/25/2003US6653315 Substituted 5-amino-imidazolo-(4,3-e)-1,2,4-triazolo(1,5-c)-pyrimidines; central nervous system diseases; Parkinson's disease
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003US20030216568 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation,compositions and use as medicaments
11/20/2003US20030216436 Potent, simplified derivatives of immunosuppressive agents
11/20/2003US20030216415 Kinase inhibitor; angiogenesis inhibitor; anticancer agents; leukemia
11/20/2003CA2485527A1 Substituted pyrroline kinase inhibitors
11/19/2003EP1362054A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
11/19/2003EP1361880A2 6-substituted pyrido-pyrimidines
11/19/2003EP1216250B1 Thienoisoxazolyl and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists
11/19/2003EP1017735B1 Compounds for electronic devices
11/18/2003US6649763 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof
11/18/2003US6649624 Useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases
11/18/2003US6649600 2,6-Dioxo or dithioxy-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo derivatives; highly potent and selective diuretics
11/13/2003WO2003093280A1 Heterotricyclyl 6-alkylidene-penems as βετα-lactamase inhibitors
11/13/2003WO2003093279A1 BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS
11/13/2003WO2003093277A1 Process for preparing 6-alkylidene penem derivatives
11/13/2003WO2003093276A1 A process for the preparation of clopidogrel
11/13/2003WO2003093265A1 Dimeric polycyclic compounds for the treatment of tumors
11/13/2003WO2003092586A2 Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
11/13/2003WO2003022806A3 Cbi analogues of cc-1065 and the duocarmycins
11/13/2003US20030212273 Pyrrolo [2,3-D] pyrimidine compounds
11/13/2003US20030212093 Imidazonaphthyridines
11/13/2003US20030209692 Reactive mesogenic benzodithiophenes
11/13/2003CA2485070A1 A process for the preparation of clopidogrel
11/13/2003CA2483538A1 Bicyclic 6-alkylidene-penems as .szlig.-lactamases inhibitors
11/13/2003CA2483533A1 Process for preparing 6-alkylidene penem derivatives
11/12/2003EP1360185A2 Carboline derivatives
11/12/2003EP1359908A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
11/12/2003EP0760657B1 Novel potent inducers of terminal differentiation and methods of use thereof
11/06/2003WO2003091256A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND NAD(P)H OXIDASE INHIBITOR CONTAINING THE SAME
11/06/2003WO2003091254A1 Triazolopyrimidines
11/06/2003WO2002060900A8 Antagonists of mcp-1 function and methods of use thereof
11/06/2003CA2483306A1 Pyrazolo[1,5-a]pyrimidine derivative and nad(p)h oxidase inhibitor containing the same
11/05/2003EP1359152A2 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
11/05/2003EP1358188A2 Antagonists of mcp-1 function and methods of use thereof
11/05/2003CN1454083A Selective androgen receptor modulators and methods for their identification design and use
11/04/2003US6642246 Quinuclidine acrylamides
11/04/2003US6641784 Tris-(2,3-epoxypropyl)isocyanurate, is presented. The optical resolver comprises an optically active tris-(epoxyalkyl) isocyanurate or its derivative, or an optically active derivative of a tris-(epoxyalkyl)isocyanurate, High
10/2003
10/30/2003WO2003088969A1 Anhydrovinblastine for the treatment of cancer
10/30/2003US20030204088 Reacting a 2,3-dihydro-p-dioxino(2,3-g)quinoline-6-(4-N-methyl piperazine compound with a pyrano(3,4-c)pyridine-3,8-dione compound to form the intermediate
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203897 2,4-Disubstituted thiazolyl derivatives
10/29/2003EP1357163A1 Reactive mesogenic benzodithiophenes
10/29/2003EP1357125A2 Process for the preparation of halogenated derivatives of vinca alcaloids
10/29/2003EP1204663B1 Novel spiro compounds with neuropeptide y antagonistic activity
10/29/2003EP1147112B1 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638943 And preparation from yohimbic acid and an alkylene (especially an oxyalkylene) diamine
10/28/2003US6638942 Spiro-indolines as Y5 receptor antagonists
10/28/2003US6638925 Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 111